Alpha-GPC improves cognitive function in mild to moderate Alzhemier's dementia.
Abstract Title: Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo- controlled trial.
Abstract Source: Clin Ther. 2003 Jan;25(1):178--93. NCBI Public Medical Research PMID: 12637119
Abstract Author(s): Maria De Jesus Moreno Moreno
CONCLUSION: The results of this study suggest the clinical usefulness and tolerability of CA in the treatment of the cognitive symptoms of dementia disorders of the Alzheimer type.
Article Published Date: Jan 01, 2003